CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 166 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $864,954 | -66.8% | 73,991 | -61.9% | 0.00% | -60.0% |
| Q2 2023 | $2,607,401 | +92.3% | 194,003 | -3.1% | 0.01% | +66.7% |
| Q4 2021 | $1,356,000 | +184.9% | 200,308 | +93.8% | 0.00% | +50.0% |
| Q1 2021 | $476,000 | +0.4% | 103,332 | -27.1% | 0.00% | -33.3% |
| Q4 2020 | $474,000 | -46.3% | 141,798 | -52.3% | 0.00% | -50.0% |
| Q3 2020 | $882,000 | -42.0% | 296,980 | -9.9% | 0.01% | -45.5% |
| Q2 2020 | $1,522,000 | -64.2% | 329,430 | -70.2% | 0.01% | -74.4% |
| Q1 2020 | $4,256,000 | -27.6% | 1,105,426 | -29.5% | 0.04% | +7.5% |
| Q4 2019 | $5,878,000 | – | 1,567,564 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |